Bruce Jackson
Stock Analyst at Benchmark
(0.84)
# 3,829
Out of 4,944 analysts
124
Total ratings
24.79%
Success rate
-26.64%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Initiates: Speculative Buy | $5 | $4.06 | +23.15% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.97 | +183.51% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.77 | +690.96% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.49 | +516.65% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $3.67 | +799.18% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $3.15 | +630.16% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $71.23 | +12.31% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $6.28 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $44.97 | +44.54% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.63 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $4.39 | +583.37% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.61 | +106.58% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.29 | +132.56% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.74 | +187.29% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.59 | +4,983.88% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.82 | +1,470.68% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.46 | +3,587.64% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.73 | +1,287.28% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $2.03 | -50.62% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.73 | +580.55% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.41 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $28.20 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.52 | +22,659.60% | 1 | Aug 8, 2022 |
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $4.06
Upside: +23.15%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.97
Upside: +183.51%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.77
Upside: +690.96%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.49
Upside: +516.65%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $3.67
Upside: +799.18%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $3.15
Upside: +630.16%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $71.23
Upside: +12.31%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.28
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $44.97
Upside: +44.54%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.63
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.39
Upside: +583.37%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.61
Upside: +106.58%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.29
Upside: +132.56%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.74
Upside: +187.29%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.59
Upside: +4,983.88%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.82
Upside: +1,470.68%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.46
Upside: +3,587.64%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.73
Upside: +1,287.28%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $2.03
Upside: -50.62%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.73
Upside: +580.55%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.41
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $28.20
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.52
Upside: +22,659.60%